Leerink Partnrs Brokers Boost Earnings Estimates for Cencora
Equities researchers at Leerink Partnrs lifted their Q3 2025 earnings estimates for Cencora in a research report issued on ...
Healthcare Dive10h
Walgreens offloads more Cencora shares
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...
Crain's Chicago Business14h
Walgreens injecting $300M in another Cencora sell-off, early settlement
In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...
Becker's Hospital Review16h
Cencora expands Sure Supply Program, adds 200 critical medications amid shortages
Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks ...
Investing19h
McKesson Corp. outlook revised to positive, ’BBB+’ rating affirmed: S&P Global
S&P Global Ratings has revised its outlook on McKesson Corp (NYSE: MCK). to positive from stable, while affirming its ’BBB+’ rating. The updated outlook is ba ...
Canaccord cuts Neurocrine Bio stock target to $163, keeps Buy rating
Biosciences stock, lowering the price target to $163 from the previous $172 while maintaining a Buy rating. The revision follows a reevaluation of the company's sales projections for its leading ...
Canaccord raises EZCORP stock target to $22, maintains Buy rating
Canaccord Genuity analyst Brian McNamara increased the price target for EZCORP (NASDAQ:EZPW) to $22.00, up from the previous ...
Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move
Walgreens Boots Alliance further reduced stake in Cencora. Walgreens reports early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of ...